Oncology Medical News about Head-and-Neck Cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prospective Trial Incorporating Pre-/Mid-Treatment [18F]-Misonidazole Positron Emission Tomography for Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
International Journal of Radiation Oncology*Biology*Physics, 08/31/09

Lee N et al. – Excellent locoregional control was observed in this series of head–and–neck cancer patients treated with concurrent platinum–based chemotherapy and intensity–modulated radiotherapy despite evidence of detectable hypoxia on the pretreatment 18F–FMISO PET/computed tomography scans of 18 of 20 patients. In this prospective study, neither the presence nor the absence of hypoxia, as defined by positive 18F–FMISO findings on the mid–treatment PET scan, correlated with patient outcome.

<< Previous
Stereotactic Body Radiotherapy for Treatment of Adrenal...

Next >>
Contemporary Risk Profile of Prostate Cancer in the United States